Please note submission is now closed for the 2016 program.
The 14th International Child Neurology Congress aims to cover all aspects of child neurology and affiliated topics. You are invited to submit abstracts on the following topics. Submissions will be considered for platform and poster presentations. All abstracts are to be submitted online and should be a maximum of 250 words. See detailed author guidelines below
Submissions Open June 1, 2015
Submissions Close Dec 16, 2015
Topics (during abstract submission, you will be asked to select one of the below mentioned topics)
- Cerebral Palsy
- Ethics and history
- Fetal and neonatal neurology
- Genetics (techniques)
- Immune-mediated disorders
- Infectious diseases
- Intellectual disability and chromosomal disorders
- Learning and behavioral disorders
- Movement disorders
- Neurocutaneous disorders
- Neurodegenerative disorders
- Neurometabolic disorders
- Neuromuscular disorders
- Ophthalmology and otology
- Other topic
- Stroke and vascular disorders
- Traumatology and critical care
- White matter disorders
On-line abstract submission is via the form below.
- Abstracts are required for all papers and posters.
- Abstracts MUST be submitted ONLINE
- The abstract submission form will ask for the following information: Title of your abstract, abstract text (maximum 250 words), abstract topics, presentation preference (platform or poster presentation) and co-authors.
In case you have questions, please contact the congress secretariat at firstname.lastname@example.org (*note: email has changed).
Preparation of your abstract
- A “blind” peer review process will be used. No identifying features such as names of hospitals, medical schools, universities, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. The names of authors and their affiliations (institutions) will be submitted on-line when you submit the abstract.
- Abstracts which have been presented to a substantially different audience, especially a local or regional one, may be submitted for consideration.
- Abstracts should state briefly and clearly an introduction, methods or description of the case results and discussion points. The maximum word count is 250 words.
- Title: The title should be as brief as possible but long enough to indicate clearly the nature of the study.
- Introduction: Describe the context of the research/case and explain its relevance and importance
- Methods: Concise description of the process by which the research was conducted
- Case Description (if applicable): Report the case using the standard medical sequence
- Results: The results or outcome of your work. If you don’t have final results yet in time for the abstract submission, you can either include any preliminaryresults that you do have, or you can briefly mention the results that you expect to obtain. Abstracts without any mention of results or indicated “to be confirmed” will not be accepted.
- Conclusion/Discussion: Discuss the reasons for particular decisions being made and highlight any important learning points or lessons.
- Acknowledgements can be mentioned in the text of the abstract
- Units and Symbols: Metric units according to the System of International Units (SI) should be used.
- Equations should use the Equation style, tab centred with the number in parentheses on the right, as shown here: I = Ioe-x(1)
- Abbreviations: Use standard abbreviations. For terms that are abbreviated, use the whole the first time, followed by the abbreviation in parenthesis. Abbreviate journal titles according to Index Medicus and give year, volume number and inclusive pages. Use references sparingly within the body of your abstract.
- References: For journals, mention first author “et al” followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (i.e. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (i.e. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.)
- International nonproprietary names and abbreviations for antiepileptic drugs as published in Epilepsia 1993; 34(6):1151, should be used. References for book chapters should consist of editor, title, city of publication, publisher, year and inclusive pages. Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
Authors are advised that abstracts without an explicit concluding sentence stating the significance of the findings will not be accepted. It is not satisfactory to say the results will be discussed. Case reports are strongly discouraged unless they present very novel and significant findings or potential therapies, as determined by the ICNC Scientfic Program Review Committee. Please include hard data such as the “n” or “p” of observations and statistical values.
Acceptance emails will be sent out in February 2016. Authors are required to confirm their plan to present at the ICNC2016 upon receipt of the acceptance email. If the abstract is withdrawn for any reason prior to the meeting, authors are responsible for notifying the ICNC2016 secretariat immediately at email@example.com (*note: email has changed)
At least one author for each abstract that is accepted for presentation in the Conference Program is expected to register and pay to attend the Conference to present their research. All of the costs to attend the Conference, including the registration fee, must be paid by presenters.